The United States will partner with Japan, India and Australia to expand the global supply of vaccines.
Ocugen COVID-19 vaccine co-development partner, Bharat Biotech shares COVAXIN Phase 3 interim results, demonstrates 81% effectiveness Nasdaq: OCGN
Ocugen COVID-19 vaccine co-development partner, Bharat Biotech shares COVAXIN Phase 3 interim results, demonstrates 81% effectiveness
Competing hospitals partner to bridge the gap in emergency care in rural South Carolina after the emergency room closes
